Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Dutogliptin (PHX1149T) in Type 2 Diabetes Mellitus on Metformin
2008-008974-30Phase 3Terminated
- Sponsor
- Phenomix Sciences
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dutogliptin + metformin with Placebo + metformin (2 arms). Primary endpoints: Change in HbA1c from baseline to Week 26 (placebo-corrected), Change in fasting plasma glucose from baseline to Week 26 (placebo-corrected) and 4 more. Started May 2009; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-008974-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008974-30.